Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11092-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11092-1-AP, RRID:AB_2082254
- Product name
- CLK2 antibody
- Antibody type
- Polyclonal
- Description
- CLK2 antibody (Cat. #11092-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer.
Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3.
RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.
Zhang Y, Chen Y, Wang B, Cai Y, Zhang M, Guo X, Wu A, Wang W, Liu N, Wang X, Gong Y, Pan J, Jin Y
Bioorganic chemistry 2024 Jul;148:107459
Bioorganic chemistry 2024 Jul;148:107459
Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3.
Ming T, Yuting L, Meiling D, Shengtao C, Jihua R, Hui Z, Wanjin C, Dian L, Tingting G, Juan C, Zhenzhen Z
Antiviral research 2024 Jan;221:105796
Antiviral research 2024 Jan;221:105796
RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.
Jin Y, Cao B, Zhang M, Zhan Q, Herman JG, Yu M, Guo M
Genes & cancer 2015 May;6(5-6):231-40
Genes & cancer 2015 May;6(5-6):231-40
No comments: Submit comment
No validations: Submit validation data